1.15 All payments of the founders' royalty are financing cash flows, although fair-value increases are charged to operating expenses

Company C · a US-listed specialty healthcare products company · SEC-style question

QuestionLowInterpretationFinancial statements, US GAAP and Regulation S-X
Area of the 10-K
Statement of cash flows; Note 2 and Note 3, contingent royalty obligation
Year
Both years
Status
Interpretation: Established from the documents; the conclusion rests on a reading of the standard or regulation.
Who acts
Chief Accounting Officer, SEC Reporting
When
Next Form 10-K (fiscal 2026)

In brief

The company pays its founders a low single-digit royalty on Product 1 net sales under an obligation assumed at its initial public offering, carried at fair value with changes in operating expenses. Every payment ([amount] in 2025) is shown in financing activities. Since 2022 fair-value increases of [amount] net have been expensed while [amount] has been paid; the report does not give the amount first recognized, so a reader cannot tell whether payments now include amounts that should be operating.

The evidence, as filed

Masked extract: Form 10-K 2025, page 65
Form 10-K 2025, page 65All payments in financing activities
Masked extract: Form 10-K 2024 (prior year), page 81
Form 10-K 2024 (prior year), page 81Prior-year roll-forward: opening 2022 fair value
Masked extract: Form 10-K 2024 (prior year), page 75. The prior-year filing
Form 10-K 2024 (prior year), page 75The prior-year filingPrior year: The 2024 Form 10-K describes the obligation in the same words and also gives no amount first recognized.

1 further page extract: screenshot withheld to protect the company’s identity. The rows below say what each shows.

What the filing shows, and what the rule requires

What the filing showsWhat the rule requires

Payment of contingent royalty obligation to the Company founders of [n] (2025), [n] (2024) and [n] (2023) wholly in financing activities; fair-value changes in operating expenses; no amount given for the obligation as first recognized

Payments presented as financing only up to the amount of the liability first recognized (with any later additions treated as a financing liability), and amounts paid above that presented in operating activities, by analogy to the guidance for contingent consideration paid after an acquisition; or a stated basis for financing classification

What we checked. Statements of cash flows, Note 2 policy, Note 3 roll-forward in both years

The rule

FASB ASC 230-10-45-15(f) and 230-10-45-17(ff) (contingent consideration payments after an acquisition; paraphrase, Codification text not reproduced)

Summary; FASB/IFRS text is copyrighted Classify cash receipts and payments as operating, investing or financing by their nature, present gross flows, include restricted cash, and disclose significant noncash activities.

Version: Text in force at the date of this review · Source: FASB Accounting Standards Codification, ASC 230-10-45 (as amended by ASU 2016-15)

Why it applies here. under the cash-flow guidance for contingent consideration (paragraph 230-10-45-15(f) and paragraph 230-10-45-17(ff), added by Accounting Standards Update 2016-15), payments made long after an acquisition are financing only up to the liability first recognized and operating for the excess. The company is not the acquirer here, so the guidance applies only by analogy, but the economics are similar: payments above the initial fair value are the cost of a royalty on sales that has already passed through operating expenses. Whether cumulative payments have reached the initial amount cannot be told from the report.

Why it matters

If cumulative payments exceed the amount first recognized, operating cash outflow is understated and financing outflow overstated by the excess in each year.

Exposure

A question for management; classification of contingent consideration payments is a recurring subject of staff comments.

Our workings

Fact

the obligation originated in the 2013 acquisition of the company by its former parent and was assumed by the company when it went public, when the company recorded the fair value of all revised payment obligations. It is remeasured each period with changes in operating expenses, and all payments are presented in financing activities.

Our computation

from 2022 to 2025 the fair-value changes total [n] ([n] + [n] + [n] - [n]) and payments total [n] ([n] + [n] + [n] + [n]); the 2025 payments equal 14.67% of the operating cash outflow ([n] / [n]).

ItemComputationResult
Fair-value changes 2022-2025[n] + [n] + [n] - [n] = [n][n]
Payments 2022-2025[n] + [n] + [n] + [n] = [n][n]
Roll-forward check[n] + [n] - [n] = [n]agrees to year-end fair value
2025 payments vs operating cash outflow[n] / [n] = 14.67%14.67%

Management’s best defense, and our reply

Management can argue that the obligation was assumed from the former parent in a capital transaction rather than in a business combination of its own, so the contingent-consideration guidance does not apply. It can argue that settling a liability assumed in that way is by nature a financing outflow. It can add that cumulative payments may still be below the fair value first recognized, so even under the analogy all payments to date would be financing. The answer: these are reasonable positions, but the report does not give the figures that would settle them, so the point stays a question.

The fix

  1. Disclose the amount at which the obligation was first recognized and the cumulative payments, and classify payments above that amount in operating activities, or state why financing classification applies to the whole payment.

Question for the company

At what amount was [wording masked] first recognized when the company assumed it, how much has been paid in total since then, and on what basis are payments that exceed the initially recognized amount (and so correspond to fair-value increases charged to operating expenses) presented in financing activities?

Evidence relied on

#What it showsTypeWhere
1All payments in financing activitiesDocumentForm 10-K 2025, page 65
2Operating cash outflow used for the proportionDocumentForm 10-K 2025, page 65
3Initial recognition at fair value; amount not givenDocumentForm 10-K 2025, page 73
4The obligation is a royalty on salesDocumentForm 10-K 2025, page 73
5Fair-value changes go through operating expensesDocumentForm 10-K 2025, page 79
6Year-end fair valueDocumentForm 10-K 2025, page 79
7Prior-year roll-forward: opening 2022 fair valueDocumentForm 10-K 2024 (prior year), page 81
8Prior-year roll-forward: 2022 paymentsDocumentForm 10-K 2024 (prior year), page 81
9Prior-year roll-forward: 2022 fair-value changeDocumentForm 10-K 2024 (prior year), page 81

Absence check

Document
Form 10-K 2025
Where it would appear
Contingent Royalty Obligation Payable to the Company founders
What is missing
the amount at which the obligation was first recognized when assumed, and cumulative payments since
Pages looked at
p.65-66 (cash flows), [n] (policy), [n] (Level 3 roll-forward)
Result
'Amended Stock Purchase Agreement' hits only p.73, the policy, which says the fair value was recorded but gives no amount; 'initially recorded' hits p.57 and [n], about deferred revenue for loyalty rewards and co-branded advertising, unrelated; 'initial fair value' and 'cumulative payments' have no hits.

Prepared by Pramanex from the company’s public SEC filings, without the company’s involvement, to show how a 10-K Pre-filing Check reads. The company is not named, and nothing on this page is a statement about any identifiable company. Observations are not an audit, review or other attestation or assurance engagement, and not legal advice. An SEC-style question is a question, not a conclusion.

Want this on your own 10-K, before you file?

Start with three free findings on your latest 10-K, or book a fixed-price 10-K Pre-filing Check.

Your next 10-K will be in draft before the audit is done.
Have it read before you file.

Start with three free findings on your latest 10-K, or book a fixed-price 10-K check. Drafts only under NDA, inside your insider trading policy.